Trends in Pharmacological Sciences. April 1995, Vol. 16 Issue 4, p117, 3 p. other
PET imaging -- Usage and Drugs -- Product development
The EC and the European Federation for Pharmaceutical Sciences co-sponsored a symposium on the potential of positron emission tomography (PET) in improving drug development and evaluation. PET's effectivity in neurological, cardiological and oncological applications was discussed. Some sectors argued that regulatory bodies would be intimidated by the extra costs involved in PET usage, but most of the participants agreed that PET will play a significant role in drug development.